Shaun Kirkpatrick is the president and chief executive officer of Research Corporation Technologies (RCT), based in Tucson. Shaun oversees RCT’s BioVentures investment portfolio and technology department, and the licensing of activities in North America, Europe and Australia. Shaun received his master’s degree in international economics and science/technology in international economics from Johns Hopkins University School of Advanced International Studies. He attended UA as a Flinn Foundation Scholar and graduated with a double major in economics and biology. He is a board member for the Flinn Foundation and the Critical Path Institute, and also serves on the boards of several companies in RCT’s BioVentures investment portfolio.
Anne McCluskey has a 25-year career in hospital pharmacy management and administration. She has been with Cardinal Health since 1997, and is currently the director of pharmaceutical distribution. She was the vice president of operations for the Resource Network at Coram Healthcare in Houston. Anne has a master’s degree from UA and an MBA from the University of Phoenix. She has also published and presented topics related to home infusion, benchmarking and productivity.
John Musil is the founder and president of Avella Specialty Pharmacy, formerly known as The Apothecary Shops. Avella is a national specialty pharmacy group of 18 stores in Arizona and seven other states. John is a 1994 graduate of the UA College of Pharmacy and a recipient of the 2010 Young Professional Achievement Award given by the Arizona Alumni Association. In 2012, Avella received the Arizona Corporate Excellence Award as the fastest growing privately held company based in Arizona and was named one of the 5.000 fastest growing companies in America by Inc. magazine.
Patrick O'Brien is the group vice president and chief legal officer of Shire Pharmaceuticals. Shire, a global company headquartered in Ireland, provides treatments in neuroscience, rare diseases, gastrointestinal and internal medicine. Patrick received both a BS Pharmacy and a PharmD from UA and completed a residency at the University of Michigan, In 1993, he earned a JD degree from UA. Before joining Shire in 2012, O'brien was a partner in several law firms and, among other positions, counsel for Johnson & Johnson, ALZA Corporation and the U.S. Food and Drug Administration.
Mark Pulido is chairman of the board at Quidel Corporation, a manufacturer of point-of-care rapid diagnostic tests. Before retiring in 2002, he served as the chairman of the board and president of BenefitPoint, Inc., an employee benefits technology company. He was also president and CEO of McKesson Corporation and Novartis Pharmaceuticals. Mark is an affiliated executive with Freeman Spogli, a private equity firm, and serves on the board of directors of Bright Now! Dental Inc. and Winebow, a wine importer and distributor. He received his bachelor’s degree in pharmacy from UA College of Pharmacy and has a master’s degree in pharmacy administration from the University of Minnesota.